With CVS Health, Tyler asserts, McKesson will "continue developing value propositions for patients utilizing our diverse set of differentiated assets and capabilities." McKesson's Financials Held Steady During a Challenging Year In 2022, when inflation was peaking and supply chains were disrupted, many U.S. businesses struggled just to survive. Check out McKesson (NYSE: MCK), a healthcare market selection that isn't talked about enough.